Prim S.A (PRM) | Stock Overview & Key Data
Prim S.A Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €18.94 on February 20, 2006
Explore how other Spanish stocks compare to their 52-week ranges: View ES Market 52-Week Insights
Key Statistics
Financial Highlights
Quarter Income Flow
Jun 30, 2021
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prim S.A
PRM
|
225.43M Mid-cap | 0.38% | 7.72% | 3.52% | -2.21% | -0.75% | 31.84% | 26.19% | 29.90% | 52.65% | 145.83% | -10.47% |
|
Grifols, S.A
GRF
|
6.09B Large-cap | -7.25% | 1.24% | -18.49% | -20.87% | -20.02% | 5.17% | -3.97% | -60.31% | -52.89% | 33.98% | 244.23% |
|
Laboratorios
ROVI
|
4.34B Large-cap | -4.70% | 3.25% | 11.63% | 25.93% | 28.02% | 58.55% | 101.84% | 68.26% | 449.09% | 1,459.62% | 743.04% |
|
Almirall S.A
ALM
|
2.76B Large-cap | -0.47% | 11.78% | -0.16% | 0.79% | -1.40% | 31.68% | 36.63% | -2.60% | -9.40% | 65.19% | -15.31% |
|
Pharma Mar S.A
PHM
|
1.68B Large-cap | -2.77% | 9.23% | 17.43% | 27.39% | 23.89% | 30.10% | 151.19% | -0.37% | 186.82% | 180.20% | 30.59% |
|
Faes Farma S.A
FAE
|
1.51B Large-cap | -2.24% | 6.90% | -6.07% | 6.90% | -8.05% | 15.38% | 50.00% | 38.33% | 75.18% | 77.12% | -48.94% |
Ownership & Short Interest
Calculate Your Prim S.A Investment Returns
Long-Term Investment Performance Analysis
Prim S.A stock price in Jul 2016 was €8.57, A €1,000.00 lump sum investment in Prim S.A made 9 years ago would be worth approximately €1,551.93 today, representing a solid return of 55.19%. This translates to an annualized return (CAGR) of 4.61%.
9 Years 9 Months Investment Scenario (Jul 2016 - Apr 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is PRM's 52-week high and low?
- In the last 52 weeks, Prim S.A reached a high of €13.95 (on October 30, 2025) and a low of €9.72 (on April 22, 2025).
- What is the market cap and P/E ratio for PRM?
- Curious about Prim S.A's size and valuation? Its market capitalization stands at 225.43M. When it comes to valuation, the P/E ratio (trailing twelve months) is 13.42, and the forward P/E (looking ahead) is 10.10.
- Does PRM pay dividends? If so, what's the yield?
- Yes, Prim S.A is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 3.70%, and the company has paid an average of €0.47 per share annually over the past 3 years.
- Who are Prim S.A's main competitors or similar companies to consider before investing?
When looking at Prim S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Grifols, S.A
GRF6.09B Healthcare Drug Manufacturers - General 5.17% -3.97% Laboratorios
ROVI4.34B Healthcare Drug Manufacturers - Specialty & Generic 58.55% 101.84% Almirall S.A
ALM2.76B Healthcare Drug Manufacturers - Specialty & Generic 31.68% 36.63% Pharma Mar S.A
PHM1.68B Healthcare Biotechnology 30.10% 151.19% Faes Farma S.A
FAE1.51B Healthcare Drug Manufacturers - Specialty & Generic 15.38% 50.00% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Prim S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Prim S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 12.52%, the Debt to Equity ratio from the most recent quarter is 11.24, and its Gross Profit Margin stands at 50.44%.
- What is the recent revenue and earnings growth for PRM?
- Looking at Prim S.A's growth, its revenue over the trailing twelve months (TTM) was €252M. Compared to the same quarter last year (YoY), quarterly revenue grew by 9.90%, and quarterly earnings saw a YoY growth of 51.30%.
- How much of PRM stock is held by insiders and institutions?
- Wondering who owns Prim S.A stock? Company insiders (like executives and directors) hold about 58.52% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 12.05%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.